Living Donor Liver Transplantation With Augmented Venous Outflow and Splenectomy: A Promised Land for Small Left Lobe Grafts.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
28
7
2022
medline:
12
10
2022
entrez:
27
7
2022
Statut:
ppublish
Résumé
Living donor liver transplantation (LDLT) using small grafts, especially left lobe grafts (H1234-MHV) (LLG), continues to be a challenge due to small-for-size syndrome (SFSS). We herein demonstrate that with surgical modifications, outcomes with small grafts can be improved. Between 2012 and 2020, we performed 130 adult LDLT using 61 (47%) LLG (H1234-MHV) in a single Enterprise. The median graft-to-recipient weight ratio was 0.84%, with graft-to-recipient weight ratio <0.7% accounting for 22%. Splenectomy was performed in 72 (56%) patients for inflow modulation before (n=50) or after (n=22) graft reperfusion. In LLG-LDLT, venous outflow was achieved using all three recipient hepatic veins. In right lobe graft (H5678) (RLG)-LDLT, the augmented graft right hepatic vein was anastomosed to the recipient's cava with a large cavotomy. Outcome measures include SFSS, early allograft dysfunction (EAD), and survival. Graft survival rates at 1, 3, and 5 years were 94%, 90%, and 83%, respectively, with no differences between LLG (H1234-MHV) and RLG (H5678). Splenectomy significantly reduced portal flow without increasing the complication rate. Despite the aggressive use of small grafts, SFSS and EAD developed in only 1 (0.8%) and 18 (13.8%) patients, respectively. Multivariable logistic regression revealed model for end-stage liver disease score and LLG (H1234-MHV) as independent risk factors for EAD and splenectomy as a protective factor (odds ratio: 0.09; P =0.03). For LLG (H1234-MHV)-LDLT, patients who underwent prereperfusion splenectomy tended to have better 1-year graft survival than those receiving postreperfusion splenectomy. LLG (H1234-MHV) are feasible in adult LDLT with excellent outcomes comparable to RLG (H5678). Venous outflow augmentation and splenectomy help lower the threshold of using small-for-size grafts without compromising graft survival.
Identifiants
pubmed: 35894443
doi: 10.1097/SLA.0000000000005630
pii: 00000658-202211000-00014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
838-845Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Ikegami T, Yoshizumi T, Sakata K, et al. Left lobe living donor liver transplantation in adults: what is the safety limit? Liver Transpl. 2016;22:1666–1675.
Lee S-G. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015;15:17–38.
Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314–323; discussion 323–325.
Olthoff KM, Smith AR, Abecassis M, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015;262:465–475; discussion 473–475.
Braun HJ, Dodge JL, Roll GR, et al. Impact of graft selection on donor and recipient outcomes after living donor liver transplantation. Transplantation. 2016;100:1244–1250.
Iwasaki J, Iida T, Mizumoto M, et al. Donor morbidity in right and left hemiliver living donor liver transplantation: the impact of graft selection and surgical innovation on donor safety. Transpl Int. 2014;27:1205–1213.
Iida T, Ogura Y, Oike F, et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation. 2010;89:1276–1282.
Ogura Y, Hori T, El Moghazy WM, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16:718–728.
Lee S-G. Techniques of reconstruction of hepatic veins in living-donor liver transplantation, especially for right hepatic vein and major short hepatic veins of right-lobe graft. J Hepatobiliary Pancreat Surg. 2006;13:131–138.
Ikegami T, Shirabe K, Soejima Y, et al. Strategies for successful left-lobe living donor liver transplantation in 250 consecutive adult cases in a single center. J Am Coll Surg. 2013;216:353–362.
de Villa VH, Chen CL, Chen YS, et al. Outflow tract reconstruction in living donor liver transplantation. Transplantation. 2000;70:1604–1608.
Yoshizumi T, Itoh S, Shimokawa M, et al. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol. 2021;74:372–379.
Yao S, Kaido T, Yagi S, et al. Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. Am J Transplant. 2019;19:2783–2794.
Botha JF, Langnas AN, Campos BD, et al. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010;16:649–657.
Emond JC, Goodrich NP, Pomposelli JJ, et al. Hepatic hemodynamics and portal flow modulation: The A2ALL Experience. Transplantation. 2017;101:2375–2384.
Halazun KJ, Przybyszewski EM, Griesemer AD, et al. Leaning to the left: increasing the donor pool by using the left lobe, outcomes of the largest single-center North American experience of left lobe adult-to-adult living donor liver transplantation. Ann Surg. 2016;264:448–456.
Troisi RI, Vanlander A, Giglio MC, et al. Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension: a randomized trial. Ann Surg. 2019;269:1025–1033.
Sánchez-Cabús S, Cherqui D, Rashidian N, et al. Left-liver adult-to-adult living donor liver transplantation: can it be improved? A Retrospective Multicenter European Study. Ann Surg. 2018;268:876–884.
Miller C, Smith ML, Fujiki M, et al. Preparing for the inevitable: the death of a living liver donor. Liver Transpl. 2013;19:656–660.
Matsushima H, Fujiki M, Sasaki K, et al. Predictive value of hepatic venous pressure gradient for graft hemodynamics in living donor liver transplantation. Liver Transpl. 2019;25:1034–1042.
Hashimoto K, Aucejo F, Quintini C, et al. Liver transplantation at Cleveland Clinic. Clin Transpl. 2010;18:195–206.
Ikegami T, Toshima T, Takeishi K, et al. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. J Am Coll Surg. 2009;208:e1–e4.
Nagino M T, DeMatteo R K, Lang H Y, et al. Proposal of a New Comprehensive Notation for Hepatectomy: The “New World” Terminology. Ann Surg. 2021;274:1–3.
Suehiro T, Shimada M, Kishikawa K, et al. Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft. Transplantation. 2005;80:964–968.
Gyu Lee S, Min Park K, Hwang S, et al. Modified right liver graft from a living donor to prevent congestion. Transplantation. 2002;74:54–59.
Quintini C, D’Amico G, Brown C, et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl. 2011;17:668–673.
Dahm F, Georgiev P, Clavien P-A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605–2610.
Soejima Y, Shimada M, Suehiro T, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl. 2003;9:581–586.
Selzner M, Kashfi A, Cattral MS, et al. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl. 2009;15:1776–1782.
Pomposelli JJ, Goodrich NP, Emond JC, et al. Patterns of early allograft dysfunction in adult live donor liver transplantation: The A2ALL Experience. Transplantation. 2016;100:1490–1499.
Sasaki K, Aucejo FN, Nair A, et al. Seamless introduction of a purely laparoscopic full-lobe living donor hepatectomy program in a North American Center. Liver Transpl. 2021;27:1203–1206.
Hernandez-Alejandro R, Ruffolo LI, Sasaki K, et al. Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases. JAMA Surg, 2022;157:524–530.
Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living-related partial liver transplantation to an adult patient. Lancet. 1994;343:1233–1234.
Abecassis MM, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy—a comprehensive report. Am J Transplant. 2012;12:1208–1217.
Lee JG, Lee K-W, Kwon CHD, et al. Donor safety in living donor liver transplantation: The Korean organ transplantation registry study. Liver Transpl. 2017;23:999–1006.
Uchiyama H, Shirabe K, Nakagawara H, et al. Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone? Am J Transplant. 2014;14:367–374.
Kitajima T, Kaido T, Iida T, et al. Left lobe graft poses a potential risk of hepatic venous outflow obstruction in adult living donor liver transplantation. Liver Transplant. 2016;22:785–795.
Hashimoto T, Sugawara Y, Tamura S, et al. One orifice vein reconstruction in left liver plus caudate lobe grafts. Transplantation. 2007;83:225–227.
Hashimoto K, Miller CM. The concept of functional graft size: an eternal theme of maximizing donor safety and recipient survival in living donor liver transplantation. Transplantation. 2022;106:696–697.
Kusakabe J, Yagi S, Sasaki K, et al. Is 0.6% reasonable as the minimum requirement of the graft-to-recipient weight ratio regardless of lobe selection in adult living-donor liver transplantation? Transplantation. 2021;105:2007–2017.
Boillot O, Delafosse B, Méchet I, et al. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet. 2002;359:406–407.
Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant. 2005;5:1397–1404.
Sato Y, Yamamoto S, Oya H, et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepatogastroenterology. 2002;49:1652–1655.
Ishizaki Y, Kawasaki S, Sugo H, et al. Left lobe adult-to-adult living donor liver transplantation: should portal inflow modulation be added? Liver Transplant. 2012;18:305–314.
Ito K, Akamatsu N, Ichida A, et al. Splenectomy is not indicated in living donor liver transplantation. Liver Transpl. 2016;22:1526–1535.
Singh A, Singhal S, Venuthurimilli A, et al. Hyper-perfusion index (HPi): a novel parameter to predict graft related outcome in adult living donor liver transplant. Transplantation. 2022;106:767–780.